Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

INCA033989 Demonstrates Promising Activity in mutCALR-Driven MPNs | AJMC

google.com·23w

FDA Grants Breakthrough Status to Novel Antibody for <b>Essential Thrombocythemia</b> - MPR

google.com·23w

Cellarity Presents on Cell State-Correcting Pipeline Programs for Sickle Cell Disease and ...

google.com·23w

ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap

google.com·23w

Takeda and Protagonist Showcase Promising Rusfertide Results at ASH 2025

google.com·23w

Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of ... - Morningstar

google.com·23w

Cellarity Presents on Cell State-Correcting Pipeline Programs for Sickle Cell Disease and ...

google.com·23w

Cellarity Presents on Cell State-Correcting Pipeline Programs for Sickle Cell Disease and ...

google.com·23w

Karyopharm to Participate in Baird&#39;s Biotech Discovery Series - Nasdaq

google.com·23w

Incyte&#39;s Rare Blood Cancer Therapy Gets FDA&#39;s Breakthrough Status - TradingView

google.com·23w

Incyte gains FDA Breakthrough designation for its candidate against <b>essential thrombocythemia</b>

google.com·23w

Incyte down after investors set high expectations for blood cancer therapy trial - TradingView

google.com·23w

INCA033989 Nets FDA Breakthrough Therapy Designation in CALR-Mutated R/R <b>Essential</b> ...

google.com·23w

<b>Polycythemia Vera</b> Market Positioned for Accelerated Development Through 2034 ... - Barchart.com

google.com·23w

Karyopharm to Participate in Baird&#39;s Biotech Discovery Series - WHO13.com

google.com·23w

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

google.com·23w

Three-Gene Model Delivers Strong Diagnostic Accuracy for Primary MF

google.com·23w

Opna Bio Showcases Multi-Functional Degraders with Potent Anti-Myeloma Activity and ...

google.com·23w

Disc Medicine, Inc. Reviews ASH Meeting Data and Operational Plans - TradingView

google.com·23w

Geron Corporation Presents New Data on Imetelstat at ASH 2025, Highlighting Clinical ...

google.com·23w

Log in to enable infinite scrolling